Erasmus University Medical Center Rotterdam

Rotterdam 3015 GD

1 studies enrolling now · 10 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia, Acute Myeloid Leukemia, Advanced and/or Metastatic Solid Tumours, Cancer, Cervical Cancer, Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Heart Failure, Hepatitis C, Chronic, Left Ventricular Dysfunction, Lymphoma

Studies at this site

• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer — Stopped early
• Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment — Running, not enrolling
• Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE — Running, not enrolling
• Reducing Lung CongestIon Symptoms in Advanced Heart Failure — Running, not enrolling
• Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL — Stopped early
• A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS) — Completed
• Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. — Status unconfirmed
• INcrease Of VAgal TonE in CHF — Stopped early
• A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed